The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nurofen Advance 200mg Tablets

Reckitt Benckiser Ireland LtdPA0979/075/001

Main Information

Trade NameNurofen Advance 200mg Tablets
Active SubstancesIbuprofen lysinate
Dosage FormFilm-coated tablet
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/075/001

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen


License statusAuthorised
Licence Issued13/07/2001
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back